Quality Control of Esophagogastroduodenoscopy Using Real-time EGD Auxiliary System
NCT ID: NCT03883035
Last Updated: 2020-01-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
1060 participants
INTERVENTIONAL
2019-03-20
2019-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AQCS for Detection of Early Cancer and Precancerous Lesions on Upper Gastrointestinal Tract
NCT04720924
Impact of Real-time Automatic Quality Control System on Colorectal Adenoma Detection
NCT04901130
Study on the Effectiveness of Gastroscope Operation Quality Control Based on Artificial Intelligence Technology
NCT04384575
High Definition Endoscopy and Optic Enhancement Endoscopy in Gastric Neoplasia: A Prospective Study
NCT02863965
Evaluation of the Clinical Effectiveness of Upper Gastrointestinal Endoscopy Reporting System
NCT05851885
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
EAS-aided group
esophagogastroduodenoscopy examination with the assistance of automatic quality-control system
automatic quality-control system
Automatic quality-control system could real-time measuring endoscopic inspection completeness, detecting gastric neoplasms and evaluating gastric mucosal visibility.
control group
conventional standard esophagogastroduodenoscopy examination without the assistance of automatic quality-control system
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
automatic quality-control system
Automatic quality-control system could real-time measuring endoscopic inspection completeness, detecting gastric neoplasms and evaluating gastric mucosal visibility.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients able to give informed consent.
Exclusion Criteria
* patients with a prior EGD examination within 1 year before the trial;
* patients with frankly upper gastrointestinal malignant lesions that were apparent on endoscopy;
* a history of upper gastrointestinal cancers;
* allergic to anaesthetic in previous medical history;
* patients refused to participate in the trial;
* the EGD procedure cannot be completed due to stenosis, obstruction, solid food, or complications of anaesthesia.
40 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yanqing Li
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yanqing Li
vice president of Qilu Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Gastroenterology, Qilu Hospital, Shandong University
Jinan, Shandong, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2019SDU-QILU-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.